"In-vivo Modulation of Synapses by Endocannabinoids"

描述（由申请人提供）：拟议研究的长期目标是研究内源性大麻素对CNS突触传递的调节作用。实验模型涉及确定的混合电和化学（神经元）突触之间的第八神经听觉初级传入和金鱼Mauthner（M-）细胞和相邻的（GABA/甘氨酸）抑制终端。虽然大多数描述内源性大麻素对突触传递的作用的研究都利用了体外系统，但这种制备方法独特地允许连续监测和量化体内电和化学传递的变化。到目前为止，据报道内源性大麻素通过大麻素1型受体（CB 1 Rs）的突触前激活来抑制化学突触传递。与此相反，我们的初步结果表明，CB 1 Rs的激活增强了M细胞上这些输入的突触传递。树突内记录，分子生物学技术和免疫细胞化学，将被用来测试特定的假设和机制的基础上修改这种激动剂诱导的突触传递。目的1，探讨不同大麻素激动剂和内源性大麻素对混合突触和抑制性终末突触效能的影响。它是基于数据表明，CB 1 R的激活导致在混合突触的电和化学传递的持久增强。这些变化还包括附近的抑制性终末。我将探讨局部应用的大麻素激动剂和内源性大麻素对单一和人口突触反应和膜电导，这是相关的听觉输入的功能的行动。目的二是研究突触传递中这些长期变化的机制。这是基于多巴胺受体拮抗剂阻断CB 1 R激活引发的增强作用的发现。我们以前曾报道存在多巴胺能神经支配和应用多巴胺诱发的突触反应的持久增强。我们将测试大麻素诱发的增强作用是通过邻近静脉曲张释放多巴胺介导的假设。我们还将询问在何种生理条件下以及从何种特定细胞类型释放内源性大麻素。拟议的研究解决了内源性大麻素对细胞间通讯的调制不仅限于化学突触，还包括间隙连接介导的电突触的概念。此外，基于与多巴胺能系统的功能性相互作用，它可以导致突触反应的长时程增强。这种调节作用可能构成一种广泛的性质，不仅与基底神经节、视网膜和新皮层等两种形式的传输共存的结构中的正常脑功能有关，而且与许多与健康有关的问题有关，如药物滥用。

DESCRIPTION (provided by applicant): The long-term objective of the proposed research is to study the modulatory actions of endocannabinoids on synaptic transmission in the CNS. The experimental model involves identified mixed electrical and chemical (glutamatergic) synapses between eighth nerve auditory primary afferents and the goldfish Mauthner (M-) cell and neighboring (GABA/Glycine) inhibitory terminals. While most studies describing the role of endocannabinoids on synaptic transmission have utilized in-vitro systems, this preparation uniquely allows continuous monitoring and quantification of changes in electrical and chemical transmission in-vivo. So far, endocannabinoids have been reported to depress chemical synaptic transmission via presynaptic activation of cannabinoid type 1 receptors (CB1Rs). Contrasting this notion, our preliminary results show that activation of CB1Rs enhances synaptic transmission at these inputs on the M-cell. Intradendritic recordings, molecular biology techniques, and immunocytochemistry, will be used to test specific hypotheses and mechanisms underlying modifications of synaptic transmission induced by this agonist. Aim 1, explores the action of different cannabinoid agonists and endocannabinoids on the synaptic efficacy of mixed synapses and inhibitory terminals. It is based on data suggesting that activation of CB1R leads to long-lasting enhancement of both electrical and chemical transmission at mixed synapses. These changes also included nearby inhibitory terminals. I will explore the actions of locally applied cannabinoid agonists and endocannabinoids on unitary and population synaptic responses and membrane conductances that are relevant for the function of this auditory input. Aim 2 is to investigate the mechanisms underlying these long-term changes in synaptic transmission. It is based on the finding that dopamine receptor antagonists block the potentiation triggered by CB1R activation. We have previously reported the presence of a dopaminergic innervation and application of dopamine evoked lasting enhancements of the synaptic response. We will test the hypothesis that cannabinoid-evoked potentiation is mediated via dopamine release from neighboring varicosities. We will also ask under which physiological conditions and from which particular cell type endocannabinoids are released. The proposed research addresses the concept that modulation of intercellular communication by endocannabinoids is not restricted to chemical synapses but also include gap-junction mediated electrical synapses. Moreover, based on a functional interaction with the dopaminergic system, it can lead to long-term potentiation of synaptic responses. This modulatory action could constitute a widespread property, relevant not only to normal brain function in structures such as the basal ganglia, retina, and neocortex where both forms of transmission co-exist, but also to numerous health-related issues such as drug abuse.